KCNC3 Gene Spinocerebellar Ataxia Type 13 Autosomal Dominant Genetic Test sale cost 4400 AED
CPT1C Gene SPG73 Genetic Test sale cost 4400 AED CPT1C Gene SPG73 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
SPTBN2 Gene Spinocerebellar Ataxia Type 5 Autosomal Dominant Genetic Test sale cost 4400 AED SPTBN2 Gene Spinocerebellar Ataxia Type 5 Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

KCNC3 Gene Spinocerebellar Ataxia Type 13 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KCNC3 gene is associated with a condition known as Spinocerebellar Ataxia Type 13 (SCA13), which is a type of hereditary ataxia. SCA13 is characterized by a progressive degeneration of the cerebellum, the part of the brain that is responsible for coordinating movement. This condition leads to symptoms such as uncoordinated movement, poor balance, and difficulty with speech. SCA13 is inherited in an autosomal dominant manner, meaning that an individual only needs a single copy of the altered gene from one parent to be affected.

A genetic test is available to identify mutations in the KCNC3 gene, which can confirm a diagnosis of SCA13. This test is crucial for individuals with a family history of the condition or those exhibiting symptoms, as it can provide a definitive diagnosis and help guide management and treatment options. Additionally, it can offer information for family planning.

In the UAE, this specific genetic test can be conducted at DNA Labs, a facility known for its comprehensive genetic testing services. The cost of the KCNC3 gene test for Spinocerebellar Ataxia Type 13 at DNA Labs UAE is 4400 AED. This test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect mutations in the KCNC3 gene. The results of this test can provide individuals and families with essential information regarding the diagnosis, prognosis, and inheritance pattern of SCA13, enabling them to make informed decisions about their health and future.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCNC3 Gene Spinocerebellar Ataxia Type 13 Autosomal Dominant Genetic Test

At DNA Labs UAE, we offer the KCNC3 Gene Spinocerebellar Ataxia Type 13 Autosomal Dominant Genetic Test for the diagnosis of this genetic disorder. The test is priced at 4400.0 AED.

Test Details

The KCNC3 gene is associated with Spinocerebellar Ataxia Type 13 (SCA13), an autosomal dominant genetic disorder. SCA13 is characterized by progressive degeneration of the cerebellum, leading to difficulties with coordination, balance, and movement.

Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously, providing a comprehensive view of an individual’s genetic makeup. In the context of SCA13, NGS genetic testing can identify mutations or variations in the KCNC3 gene that may be responsible for the development of the disorder.

By analyzing the KCNC3 gene through NGS, our team of qualified neurologists and geneticists can determine if an individual carries any disease-causing mutations or variations. This information can help with diagnosis, prognosis, and genetic counseling for individuals and their families affected by SCA13.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the KCNC3 Gene Spinocerebellar Ataxia Type 13 Autosomal Dominant Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with SCA13.

Our team of experts will guide you through the testing process and provide appropriate counseling and guidance based on the test results.

For more information or to schedule a test, please contact our Genetics Department.

Test Name KCNC3 Gene Spinocerebellar ataxia type 13 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCNC3 Gene Spinocerebellar ataxia type 13, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNC3 Gene Spinocerebellar ataxia type 13, autosomal dominant
Test Details

The KCNC3 gene is associated with Spinocerebellar Ataxia Type 13 (SCA13), an autosomal dominant genetic disorder. SCA13 is characterized by progressive degeneration of the cerebellum, leading to difficulties with coordination, balance, and movement.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, providing a comprehensive view of an individual’s genetic makeup. In the context of SCA13, NGS genetic testing can identify mutations or variations in the KCNC3 gene that may be responsible for the development of the disorder.

By analyzing the KCNC3 gene through NGS, healthcare professionals can determine if an individual carries any disease-causing mutations or variations. This information can help with diagnosis, prognosis, and genetic counseling for individuals and their families affected by SCA13.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics. They can provide appropriate counseling and guidance based on the test results.

SKU: TEST-2056 Category:

Related products